PMV Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$5.68 | $223.86 M | -2.51 | 58 | $0 |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.67 | $56.28 M | -5.86 | 2 | $0 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$27.36 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.69 | $243.38 M | -1.59 | 133 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$9.80 | $652.38 M | -6.03 | 28 | $0 |
MNOV
MediciNova, Inc. |
$1.84 | $67.19 M | -8.06 | 13 | $1.00 M |
MOLN
Molecular Partners AG |
$5.30 | $135.05 M | -2.03 | 167 | $7.04 M |
OPT
Opthea Limited |
$4.41 | $214.34 M | -1.04 | 33 | $124,666 |
PEPG
PepGen Inc. |
$2.07 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$19.23 | $843.31 M | -5.8 | 83 | $0 |
RLYB
Rallybio Corporation |
$0.88 | $61.34 M | -0.79 | 43 | $0 |
TRDA
Entrada Therapeutics, Inc. |
$13.08 | $531.37 M | 22.81 | 177 | $129.01 M |
VIGL
Vigil Neuroscience, Inc. |
$2.09 | $172.89 M | -2.17 | 64 | $0 |